MarginsXMarginsX
Home › Markets › Industrials › QTRX

Quanterix Corporation (QTRX)

QTRX trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.84
-3.07% on the day
Market cap
$134.8M
Micro cap
Revenue · 2025
$138.9M
+1.1% on 2024
Net income · 2025
-$107.2M
-77.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1503274/000150327426000013/0001503274-26-000013-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerQTRX on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year2017
SEC CIK0001503274
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$138.9M
Net income-$107.2M
Operating income-$125.5M
Net margin-77.1%
Operating margin-90.4%
Revenue growth+1.1%
Cash$29.8M
Total assets$418.8M
P/E (computed)Net income was not positive
P/S (computed)1.0×

Warning signs

Cash runway
7.7 months
$35.9M cash at September 30, 2026
Share count, 1 year
+1.6%
2025-11-04 to 2026-11-02 · +25.5% over 3 years
Going-concern doubt
No
10-Q filed November 9, 2026
Insider net buying, 12 months
$296K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-09
Cash and burn$35.9M cash; operating cash flow -$14.0M a quarter.Report 2026-09-30
Shares outstanding47,478,422 (2026-11-02); 46,710,797 a year earlier; 37,829,746 three years earlier.Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG LLP, Boston, Massachusetts, United States; changed auditors 1 time in 24 months8-K 4.01 2025-05-14
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $296K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$35.0M-$21.6M-$16.2M$35.9MNo debt tags$148.2M10-Q 2026-11-09
Q2 2026
2026-06-30
$32.9M-$48.9M-$5.1M$44.2MNo debt tags$153.4M10-Q 2026-08-10
Q1 2026
2026-03-31
$36.4M-$17.5M-$18.1M$36.2MNo debt tags$145.0M10-Q 2026-05-06
Q4 2025
2025-12-31
$43.9M-$23.1M-$16.4M$29.8MNo debt tags$138.9M10-K 2026-03-02
Q3 2025
2025-09-30
$40.2M-$33.5M-$41.2M$38.3MNo debt tags$130.2M10-Q 2026-11-09
Q2 2025
2025-06-30
$24.5M-$30.0M-$5.7M$132.9MNo debt tags$125.8M10-Q 2026-08-10
Q1 2025
2025-03-31
$30.3M-$20.5M-$13.9M$76.5MNo debt tags$135.7M10-Q 2026-05-06
Q4 2024
2024-12-31
$35.2M-$11.6M-$4.3M$56.7MNo debt tags$137.4M10-K 2026-03-02

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32025-06-16
Latest annual report10-K2026-03-02
Latest quarterly / interim10-Q2026-11-09
Latest current report8-K2026-11-09
Latest proxyDEFA14A2026-05-08

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.2%
1 month-7.0%
3 months+2.4%
Year to date-53.9%
1 year-44.9%
From 52-week high-63.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
SEERSeer Inc.$1.48-5.73%$82.6M
LABStandard BioTools Inc.$0.6210-12.21%$245.2M
NAUTNautilus Biotechnology Inc.$2.10-9.48%$267.5M
HBIOHarvard Bioscience Inc.$8.91-5.96%$40.7M
RPIDRapid Micro Biosystems Inc.$0.7400+13.67%$37.1M
PRPOPrecipio Inc.$19.96-9.81%$35.8M
EYPTEyePoint Inc.$0.3076+0.52%$35.0M
PACBPacific Biosciences of California Inc.$1.84-6.12%$575.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier